Chemo Fog pp 13-18 | Cite as

Oncology Nurse’s Perspective

  • Jamie S. Myers
Chapter
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 678)

Abstract

Oncology nurses are increasingly recognizing the importance of chemotherapy-related cognitive impairment (CRCI) in the lives of their patients and are contributing to the state of the knowledge in this field of study. The Oncology Nursing Society has included treatment related changes in cognitive function as a priority in the 2009–2013 “Oncology Nursing Society Research Agenda and Priorities”. Related educational programming has been included at national nursing symposia. A brief review of some research conducted by oncology nurses is described.

Keywords

Breast Cancer Cognitive Function Breast Cancer Survivor Oncology Nurse Unpleasant Symptom 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Ahles TA, Saykin AJ. Cognitive effects of standard-dose chemotherapy in patients with cancer. Cancer Invest 2001; 19:812–820.PubMedCrossRefGoogle Scholar
  2. 2.
    Wefel JS, Lenzi R, Theriault RL et al. The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: results of a prospective, randomized longitudinal trial. Cancer 2004; 100:2292–2299.PubMedCrossRefGoogle Scholar
  3. 3.
    Tannock IF, Ahles TA, Ganz PA et al. Cognitive impairment associated with chemotherapy for cancer: report of a workshop. J Clin Oncol 2004; 22:2233–2239.PubMedCrossRefGoogle Scholar
  4. 4.
    Doorenbos AZ, Berger AM, Brohard-Holbert C et al. ONS Research Priorities Survey. Oncol Nurs Forum 2008; 35:E100–E107.PubMedCrossRefGoogle Scholar
  5. 5.
    Oncology Nursing Society. Oncology Nursing Society 2009–2013 Research Agenda and Priorities. 2009. http://www.ons.org/research/information. Accessed 2009.Google Scholar
  6. 6.
    Ahles TA, Saykin A. Breast cancer chemotherapy-related cognitive dysfunction. Clin Breast Cancer 2002; 3(Suppl 3):S84–S90.PubMedCrossRefGoogle Scholar
  7. 7.
    Brown KA, Esper P, Kelleher LO et al. Chemotherapy and Biotherapy Guidelines and Recommendations for Practice. Pittsburgh: Oncology Nursing Society, 2001.Google Scholar
  8. 8.
    Klemp JR, Stanton AL, Kimler BF et al. Evaluating the effects of chemotherapy on cognitive function and quality of life in premenopausal women with breast cancer. Paper presented at: San Antonio Breast Cancer Symposium 2006; San Antonio.Google Scholar
  9. 9.
    Lezak MD, Howieson DB, Loring EW. Neuropsychological Assessment. 4th ed. New York: Oxford University Press; 2004.Google Scholar
  10. 10.
    Meyers CA. Neurocognitive dysfunction in cancer patients. Oncology 2000; 14(1):75–79.PubMedGoogle Scholar
  11. 11.
    Barnes DE, Cauley JA, Lui LY et al. Women who maintain optimal cognitive function into old age. J Am Geriatr Soc 2007; 55:259–264.PubMedCrossRefGoogle Scholar
  12. 12.
    Grady D, Yaffe K, Kristof M et al. Effect of postmenopausal hormone therapy on cognitive function: the heart and estrogen/progestin replacement study. Am J Med 2002; 113(7):543–548.PubMedCrossRefGoogle Scholar
  13. 13.
    Shumaker SA, Legault C, Kuller L et al. Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: women’s health initiative memory study. J Am Med Assoc 2004; 291(24):2947–2958.CrossRefGoogle Scholar
  14. 14.
    Yaffe K, Barnes DE, Lindquist K et al. Endogenous sex hormone levels and risk of cognitive decline in an older biracial cohort. Neurobiol Aging 2007; 28(2):171–178.PubMedCrossRefGoogle Scholar
  15. 15.
    Cimprich B, Ronis DL. Attention and symptom distresss in women with and without breast cancer. Nurs Res 2001; 50(2):86–94.PubMedCrossRefGoogle Scholar
  16. 16.
    Cimprich B, So H, Ronis DL et al. Pre-treatment factors related to cognitive functioning in women newly diagnosed with breast cancer. Psycho-oncology 2005; 14:70–78.PubMedCrossRefGoogle Scholar
  17. 17.
    Bender CM, Sereika SM, Berga SL et al. Cognitive impairment associated with adjuvant therapy in breast cancer. Psycho-oncology 2006; 15:422–430.PubMedCrossRefGoogle Scholar
  18. 18.
    Von Ah D, Harvison K, Carpenter J et al. Cognitive function in breast cancer survivors compared to healthy age-and education-matched women. Paper presented at: Oncology Nursing Society 10th Annual National Conference on Cancer Nursing Research 2009; Orlando FL.Google Scholar
  19. 19.
    Myers JS, Teel C. Oncology nurses’ awareness of cognitive impairment secondary to chemotherapy. Clin J Oncol Nurs 2008; 12:725–729.PubMedCrossRefGoogle Scholar
  20. 20.
    Jansen CE, Miaskowski CA, Dodd MJ et al. A meta-analysis of the sensitivity of various neuropsychological tests used to detect chemotherapy-induced cognitive impairment in patients with breast cancer. Oncol Nurs Forum 2007; 34:997–1005.PubMedCrossRefGoogle Scholar
  21. 21.
    Thielen J. Women’s experiences of living with neurocognitive changes while undergoing chemotherapy for breast cancer. Paper presented at: ONS 10th National Conference on Cancer Nursing Research 2009; Orlando FL.Google Scholar
  22. 22.
    Von Ah D. Cognitive dysfunction and its relationship to quality of life in African American and caucasian breast cancer survivors. Paper presented at: ONS 10th Annual National Conference on Cancer Nursing Research 2009; Orlando FL.Google Scholar
  23. 23.
    Jansen C. Chemotherapy-related cognitive changes in breast cancer patients. Paper presented at: ONS 10th Annual Conference on Cancer Nursing 2009; Orlando FL.Google Scholar
  24. 24.
    Jansen CE, Miaskowski C, Dodd M et al. Chemotherapy-induced cognitive impairment in women with breast cancer: a critique of the literature. Oncol Nurs Forum 2005; 32:329–342.PubMedCrossRefGoogle Scholar
  25. 25.
    Jansen C, Miaskowski C, Dodd M et al. Potential mechanisms for chemotherapy-induced impairments in cognitive function. Oncol Nurs Forum 2005; 32:1151–1163.PubMedCrossRefGoogle Scholar
  26. 26.
    Myers JS. Proinflammatory cytokines and sickness behavior: Implications for symptoms of depression and cancer. Oncol Nurs Forum 2008; 35:802–807.PubMedCrossRefGoogle Scholar
  27. 27.
    Myers JS. Chemotherapy-related cognitive impairment: Neuroimaging, neuropsychologic testing and the neuropsychologist. Clin J Oncol Nurs 2009; 13(4):413–21.PubMedCrossRefGoogle Scholar
  28. 28.
    Myers JS, Pierce J, Pazdernik T. Neurotoxicology of chemotherapy as it relates to cytokine release, the blood brain barrier and cognitive impairment. Oncol Nurs Forum 2008; 35:916–920.PubMedCrossRefGoogle Scholar
  29. 29.
    Lenz ER, Pugh LC, Milligan RA et al. The middle-range theory of unpleasant symptoms: an update. ANS Adv Nurs Sci 1997; 19(3):14–27.CrossRefGoogle Scholar
  30. 30.
    Lenz ER, Suppe F, Gift AG et al. Collaborative development of middle-range nursing theories: toward a theory of unpleasant symptoms. ANS Adv Nurs Sci 1995; 17(3):1–13.PubMedCrossRefGoogle Scholar
  31. 31.
    Hess LM, Insel KC. Chemotherapy-related change in cognitive function: a conceptual model. Oncol Nurs Forum 2007; 24:981–994.CrossRefGoogle Scholar
  32. 32.
    Myers JS. A comparison of the theory of unpleasant symptoms and the conceptual model of chemotherapy-related changes in cognitive function. Oncol Nurs Forum 2009; 36:E1–E10.PubMedCrossRefGoogle Scholar
  33. 33.
    Barton D, Loprinzi C. Novel approaches to preventing chemotherapy-induced cognitive dysfunction in breast cancer: The art of the possible. Clin Breast Cancer 2002; 3(Suppl 3):S121–S127.PubMedCrossRefGoogle Scholar
  34. 34.
    Johnson M, Henke Yarbro C. Principles of oncology nursing. In: Holland JF, Frei E, eds. Cancer Medicine. 5th ed. Hamilton: Decker, Inc; 2000.Google Scholar
  35. 35.
    Oncology Nursing Society. Oncology services in the ambulatory setting (Position statement). 2006. http://www.ons.org/pubications/postions/RevAmbulatoryPractice.shtml. Accessed 2007.Google Scholar
  36. 36.
    Polovich M, Olsen M, Whitford J eds. Chemotherapy and Biotherapy Guidelines and Recommendations for Practice. 3rd ed. Pittsburgh: Oncology Nursing Society, 2009.Google Scholar

Copyright information

© Landes Bioscience and Springer Science+Business Media 2010

Authors and Affiliations

  • Jamie S. Myers
    • 1
  1. 1.School of NursingUniversity of KansasKansas CityUSA

Personalised recommendations